Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain

NCT ID: NCT06390150

Last Updated: 2025-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2030-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this interventional study is to learn if dorsolateral spinal cord stimulation (DL-SCS) can treat focal post-surgical, medically refractory neuropathic pain. The main question it aims to answer is:

\- How does DL-SCS compare to traditional SCS and no treatment for treating post-surgical neuropathic pain?

Participants will be asked to

* trial combinations of stimulation across blocks of weeks (randomized cross-over)
* rate their pain after each stimulation trial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neuropathic pain resulting from injury to the somatosensory nervous system can be a persistent and debilitating condition of spontaneous and unprovoked symptoms. For patients with chronic neuropathic pain that does not respond to conservative therapy, spinal cord stimulation (SCS) may be considered. SCS has been established as an effective and sustained treatment for neuropathic pain, but may deliver treatment to more than just the pain area. Dorsolateral spinal cord stimulation (DL-SCS) may provide a more focal alternate target for spinal stimulation. The aim of this study is to investigate DL-SCS as a therapeutic option for post-surgical, medically refractory neuropathic pain. This is a prospective, randomized, double-blind controlled crossover trial to investigate the efficacy of DL-SCS and midline SCS (M-SCS) compared to sham stimulation for the diagnosis of post-surgical neuropathic pain. Each participant will be implanted with two electrodes and will crossover into each stimulation program in a randomized order to serve as their own control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative Neuropathic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This study will be conducted as a placebo-controlled, crossover, randomized clinical trial of the intervention dorsolateral spinal cord stimulation (DL-SCS) for the indication post-surgical focal neuropathic pain. Study arm order will be randomly generated and known only to the programmer. Once participants have crossed over into all study arms, they will be set on their best program and enter long-term observation.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DL-SCS Only

The DL-SCS electrode will be activated with a high-frequency paresthesia-free program.

Group Type EXPERIMENTAL

Spinal Cord Stimulator

Intervention Type DEVICE

The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.

Stimulation Off

Both electrodes will be programmed for sham stimulation.

Group Type PLACEBO_COMPARATOR

Spinal Cord Stimulator

Intervention Type DEVICE

The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.

M-SCS Only

The M-SCS electrode will be activated with a high-frequency, paresthesia free program.

Group Type EXPERIMENTAL

Spinal Cord Stimulator

Intervention Type DEVICE

The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.

DL-SCS + M-SCS

Both DL-SCS and M-SCS will be activated with high-frequency, paresthesia free programs.

Group Type EXPERIMENTAL

Spinal Cord Stimulator

Intervention Type DEVICE

The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinal Cord Stimulator

The spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosis of neuropathic pain following a surgical procedure
2. A minimum of 50% of pain should be limited to one body part, defined as one limb or one side of trunk.
3. Failed conservative therapies (medication, physiotherapy)
4. Disability more than 6 months

Exclusion Criteria

1. Previous implantation with SCS (i.e. revision surgery)
2. Any underlying condition that would preclude an MRI
3. Untreated psychiatric conditions or substance use disorder
4. Existing medical conditions that would preclude from SCS (history of recurrent infections, uncontrolled cancer, etc.)
5. Surgically treatable lesion (e.g. spinal stenosis, disc herniation)
6. Lack of capacity (e.g. significant cognitive impairment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nova Scotia Health Authority

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lutz Weise

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lutz Weise, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Nova Scotia Health Authority

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Elizabeth Health Science Centre

Halifax, Nova Scotia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lutz Weise, MD, PhD

Role: CONTACT

902-472-6850

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MIDL-SCS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Spinal Cord Stimulation
NCT05885061 RECRUITING NA
Sensory Spinal Cord Stimulation
NCT07095036 RECRUITING NA